<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Afferent — The Tract monthly neurology brief</title><link>https://thetract.org/brief/</link>
<description>Two pages a month: what changed in neurology, how strong the evidence is, and whether it should change practice.</description><language>en</language>
<item><title>Afferent No. 01 — October 2026</title><link>https://thetract.org/brief/</link>
<guid isPermaLink="false">afferent-2026-10</guid><pubDate>Fri, 06 Nov 2026 09:00:00 +0000</pubDate><description>Tenecteplase before thrombectomy may help cardioembolic stroke more than atherosclerotic · The first joint European guideline on infectious encephalitis puts a clock on aciclovir · ECTRIMS in two minutes: five things from MSToronto2026 · Plasma p-tau217 predicts who becomes impaired — over years, not months · Hype check: An accelerated-approval filing for CNM-Au8, built on trials that missed their primary endpoints</description>
<enclosure url="https://thetract.org/brief/afferent-2026-10.pdf" type="application/pdf" length="1102259"/></item>
</channel></rss>
